← Back to Search

Video DOT+ for Opioid Use Disorder

N/A

Waitlist Available

Led By Kenneth Silverman, Ph.D.

Research Sponsored by Johns Hopkins University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 weeks

Awards & highlights

Study Summary

This trial will test a new way to get people with opioid addiction into treatment and keep them there, using a combination of video-based observation and incentives.

Eligible Conditions

Opioid Use Disorder

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Buprenorphine Treatment Adherence

Secondary outcome measures

Linkage to Treatment

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Video DOT+Experimental Treatment1 Intervention

Participants in this group will be referred to receive office-based buprenorphine treatment and will receive financial incentives for taking their daily buprenorphine dose.

Group II: Usual CareActive Control1 Intervention

Participants in this group will be referred to receive office-based buprenorphine treatment

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Video DOT+

2019

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor

2,256 Previous Clinical Trials

14,820,030 Total Patients Enrolled

Centers for Disease Control and PreventionFED

875 Previous Clinical Trials

22,477,361 Total Patients Enrolled

Kenneth Silverman, Ph.D.Principal InvestigatorJohns Hopkins School of Medicine

10 Previous Clinical Trials

1,024 Total Patients Enrolled

Media Library

Video DOT+ Clinical Trial Eligibility Overview. Trial Name: NCT03677986 — N/A

Opioid Use Disorder Research Study Groups: Usual Care, Video DOT+

Opioid Use Disorder Clinical Trial 2023: Video DOT+ Highlights & Side Effects. Trial Name: NCT03677986 — N/A

Video DOT+ 2023 Treatment Timeline for Medical Study. Trial Name: NCT03677986 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this research open to subjects of all ages, or are there age restrictions?

"This medical trial is recruiting patients above the age of majority and below a century old."

Answered by AI

What is the current enrollment size of this research project?

"Affirmative. Clinicaltrials.gov confirms that this scientific study is presently enrolling patients; it was uploaded on April 22nd 2019 and recently modified on May 6th 2022. This study requires 64 volunteers to be recruited from one medical facility."

Answered by AI

Is enrollment in this experiment currently open?

"Indeed, according to the clinicaltrials.gov website, this research is presently enrolling participants. It was first made available on April 22nd 2019 and its most recent update was carried out on May 6th 2022. The project requires 64 volunteers from 1 medical facility."

Answered by AI

Who can be included in the experiment for this research?

"In order to qualify for this clinical trial, individuals must have suffered from a drug overdose and fall between the age limits of 18 and 100. At present, 64 volunteers are needed for enrolment."

Answered by AI

Recent research and studies

Psychology of Addictive BehaviorsJournal

Technology-assisted Opioid Education for Out-of-treatment Adults with Opioid Use Disorder.

Toegel, Forrest, Matthew D. Novak, Andrew M. Rodewald, Jeannie-Marie Leoutsakos, Kenneth Silverman, and August F. Holtyn. 2022. “Technology-assisted Opioid Education for Out-of-treatment Adults with Opioid Use Disorder.”. Psychology of Addictive Behaviors. American Psychological Association (APA). doi:10.1037/adb0000769.

Psychology of Addictive BehaviorsJournal

Technology-assisted Opioid Education for Out-of-treatment Adults with Opioid Use Disorder.

clinicaltrials.govStudy

Buprenorphine Treatment Engagement and Overdose Prevention

2019. "Buprenorphine Treatment Engagement and Overdose Prevention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03677986.